<aside> 💡

Faeve’s brand journey began in 2017 with the founding of Faeve Plant Therapies, secured by Trademark Number 88666990 through our trademark attorneys. In 2021, we received a cease and desist letter from Plant Therapy, a large essential oil company. Their president, Chris Jones, aggressively threatened legal action, including personal and business asset seizure. After reviewing our position with legal counsel, we were advised that we had properly secured our trademark and had a strong case. However, due to the industry landscape and the value of the Faeve brand, we opted to settle out of court. As part of the settlement, Plant Therapy compensated us to rebrand and transition all materials and legal entities to “Faeve.” We subsequently secured the Faeve trademark (Trademark Number 97059313) and registered a DBA as Faeve Apothecary.

During this process, we also discovered that Faeve Plant Therapies (FPT) was, without my knowledge or consent, listed by the IRS as owned by my previous medical company, Mulberry Integrative Medicine. To resolve this, we dissolved FPT and transferred all assets to a newly formed entity, Faeve, LLC, following all proper legal protocols. This transition was completed in 2025, which is why historical sales are attributed to FPT rather than Faeve, LLC.

Regarding intellectual property, Kevo-Prophen has been submitted for trademark protection (Trademark Number 99216533), and we are currently finalizing the proprietary blend of oils for Kevo, which will also be trademarked. Our legal team has confirmed—after consultation with four separate attorneys—that patents are not available for our formulations, as they are comprised almost entirely of plant-based ingredients. However, we are actively securing trademarks for our blends, which will be the same approach for the upcoming SunG product. The process for our diabetes support product will differ due to its unique formulation and regulatory pathway.

</aside>